GlassScriptPhysician profile
Mark David Pedigo
NPI 1144798570
$12,325.61
in general payments reported to CMS, 2019-2025
64 companies · $3,336 in 2025
The $3,336 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,580 · 2022: $2,223 · 2023: $3,120 · 2024: $2,066 · 2025: $3,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,521.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,457.83 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,291.40 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,272.46 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $565.57 | 2022-2025 | |
| Lilly USA, LLC | $564.62 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Glaxosmithkline, LLC. | $550.01 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $529.60 | 2021-2025 | Evenity, Repatha, Prolia |
| Otsuka America Pharmaceutical, INC. | $489.61 | 2023-2025 | Rexulti |
| Pfizer INC. | $448.92 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $421.53 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $417.55 | 2021-2025 | Spravato, Xarelto, Invega Sustenna |
| Astellas Pharma US INC | $304.36 | 2021-2025 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $302.95 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $302.72 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $261.13 | 2021-2025 | Xifaxan, Trulance |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $234.92 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $232.06 | 2021-2025 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $228.11 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Merck Sharp & Dohme LLC | $198.12 | 2021-2025 | Belsomra, Capvaxive, Gardasil 9 |
| Lundbeck LLC | $197.45 | 2024-2025 | Rexulti, Vyepti |
| Corcept Therapeutics | $192.73 | 2023-2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $186.24 | 2021-2023 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $167.04 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $155.85 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $130.29 | 2023-2025 | Auvelity |
| Sumitomo Pharma America, INC. | $105.44 | 2025 | Gemtesa |
| Nevro Corp. | $93.08 | 2022-2024 | Senza |
| Sanofi Pasteur INC. | $76.94 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $54.96 | 2021-2023 | Oxlumo |
| Aimmune Therapeutics, INC. | $51.97 | 2024 | |
| Radius Health, INC. | $51.67 | 2025 | Tymlos |
| Esperion Therapeutics, INC. | $50.29 | 2025 | Nexletol |
| Abbott Laboratories | $40.01 | 2024 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $38.35 | 2024-2025 | Austedo Xr, Austedo Xr |
| Dynavax Technologies Corporation | $36.91 | 2024-2025 | Heplisav-B |
| Eisai INC. | $35.86 | 2021 | |
| Biogen, INC. | $33.35 | 2021 | |
| Nestle Healthcare Nutrition INC. | $32.91 | 2023 | |
| Amarin Pharma, INC. | $27.50 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.31 | 2022 | |
| Currax Pharmaceuticals LLC | $27.17 | 2022-2023 | Contrave |
| Genentech USA, INC. | $26.52 | 2021 | |
| Inari Medical, INC. | $25.76 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Mylan Specialty L.P. | $25.44 | 2024 | Yupelri |
| Xeris Pharmaceuticals, INC. | $24.94 | 2023 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $24.82 | 2024 | Inspire |
| Shield Therapeutics INC | $24.65 | 2025 | |
| Seqirus USA INC | $22.73 | 2024 | Flucelvax, Fluad |
| Amneal Pharmaceuticals LLC | $22.42 | 2025 | Crexont |
| Tris Pharma INC | $21.76 | 2025 | Dyanavel Xr |
| Recordati_rare_diseases_inc. | $19.99 | 2025 | Isturisa |
| Sunovion Pharmaceuticals INC. | $19.69 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.76 | 2025 | Zilretta |
| Acella Pharmaceuticals, LLC | $18.32 | 2025 | NP Thyroid 60 |
| Corium, LLC | $16.47 | 2022 | |
| Ibsa Pharma INC. | $16.44 | 2021 | |
| Boston Scientific Corporation | $16.01 | 2025 | Enhance Transcarotid Peripheral Access Kit |
| Phadia US INC. | $15.56 | 2021 | |
| Optinose US, INC. | $15.37 | 2021 | |
| Ironwood Pharmaceuticals, INC | $14.29 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.23 | 2021 | |
| Avvisto Therapeutics, LLC | $13.10 | 2024 | Cycloset |
| Upsher-Smith Laboratories LLC | $11.37 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
Farxiga $648Rexulti $643Ozempic $567Rybelsus $419Ubrelvy $415Vraylar $414Kerendia $409Leqvio $287Mounjaro $271Nurtec Odt $268Cologuard Collection Kit $235Jardiance $227Breztri $222Qulipta $213Wegovy $212Xyosted $204Korlym $193Zepbound $192Spravato $186Airsupra $170Caplyta $167Dexcom G6 Transmitter $160Shingrix $157Voquezna $156Veozah $149Xifaxan $145Arexvy $134Repatha $134Auvelity $130Xarelto $123Evenity $109Gemtesa $105Otezla $95.20Zavzpret $93.45Zenpep $84.88Toujeo $82.34Tzield $82.25Comirnaty $79.62Eliquis $79.13Prolia $78.06Nocdurna $77.09Tlando $77.09Prevnar 20 $63.20Senza $60.43Belsomra $53.39Tymlos $51.67Nexletol $50.29Paxlovid $50.25Trelegy Ellipta $48.80Vyepti $43.91Freestyle Libre 3 $40.01Capvaxive $39.19Gardasil 9 $39.19Austedo Xr $38.35Kisunla $37.10Heplisav-B $36.91Soliqua 100/33 $36.76Linzess $36.50Verquvo $35.40Trulance $35.17Synthroid $33.32Trintellix $32.86Flublok Quadrivalent Northern Hemisphere $31.06Fluzone High-Dose $31.06Emgality $26.96Flowtriever Catheter, S $25.76Ct Thrombectomy System Kit $25.76Yupelri $25.44Gvoke Hypopen $24.94Inspire $24.82Accrufer $24.65Fluad $22.73Flucelvax $22.73Myrbetriq $22.54Crexont $22.42Steglatro $21.79Lagevrio $21.79Dyanavel Xr $21.76Gardasil $20.13Vyndamax $20.04Isturisa $19.99Oxlumo $19.51Zilretta $18.76NP Thyroid 60 $18.32Penbraya $16.36Trumenba $16.36Invega Sustenna $16.28Enhance Transcarotid Peripheral Access Kit $16.01Fluzone Quadrivalent Northern Hemisphere $15.51Contrave $15.36Cycloset $13.10Creon $8.33Viberzi $5.42
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pedigo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.